I am a Clinical Senior Lecturer at Imperial College, London and the George Institute for Global Health and Honorary Consultant in Obstetrics and Gynaecology at Imperial College Healthcare NHS Trust.
My research aims to make best use of the data and blood samples collected as part of routine maternity care. With fantastic colleagues, I have been awarded funding from the NIHR, charities and philanthropic organisations.
With strong engagement with those who use our services, I am leading a new infection and immunity surveillance platform for London, bringing together a UK Mother and Baby data collaborative and trialling prevention of type 2 diabetes in women affected by diabetes in pregnancy.
My PhD at Imperial College investigated the fetal and maternal inflammatory response in Fetal Growth Restriction.
Following this, I won a fellowship with Professor Dame Sally Davies, England CMO, as editor-in-chief of the CMO’s annual report, ‘Women: the health of the 51%.’ With Dame Sally, I worked with leaders in the field to bring a host improvements for women's health into policy and practice in the UK.
As an National Institute of Health Research Academic Clinical Lecturer, I investigated self-monitoring of maternal cardiovascular health and prevention of Gestational Diabetes.
During the COVID-19 pandemic, I was seconded as clinical adviser to Professor Sir Chris Whitty, England CMO, and produced rapid evidence reviews on coronavirus infection in pregnancy and in children, which I presented to SAGE and formed the basis of clinical guidelines for the UK. I am an advisor to the WHO on maternal and perinatal research in pandemics.
I lead a new clinical service to provide post-birth contraception for all women in NW London to enable access to reliable family planning before discharge from maternity services. I am working with colleagues to evaluate this and support national roll-out.
et al., 2023, Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis, American Journal of Obstetrics and Gynecology, Vol:228, ISSN:0002-9378, Pages:161-177
et al., 2023, Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis, Bmj Global Health, Vol:8, ISSN:2059-7908
et al., 2022, Current practice in the diagnosis and management of fetal growth restriction: An international survey, Acta Obstetricia Et Gynecologica Scandinavica, Vol:101, ISSN:0001-6349, Pages:1431-1439
et al., 2022, Remote multimodality monitoring of maternal physiology from the first trimester to postpartum period: study results., Journal of Hypertension, Vol:40, ISSN:0263-6352, Pages:2280-2291
et al., 2022, Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples, Plos One, Vol:17, ISSN:1932-6203, Pages:e0273966-e0273966